0001043961-17-000006.txt : 20170426 0001043961-17-000006.hdr.sgml : 20170426 20170426162109 ACCESSION NUMBER: 0001043961-17-000006 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170426 DATE AS OF CHANGE: 20170426 EFFECTIVENESS DATE: 20170426 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSGENOMIC INC CENTRAL INDEX KEY: 0001043961 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 911789357 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-285542 FILM NUMBER: 17784629 BUSINESS ADDRESS: STREET 1: 12325 EMMET ST CITY: OMAHA STATE: NE ZIP: 68164 BUSINESS PHONE: 4027385480 MAIL ADDRESS: STREET 1: 12325 EMMET STREET CITY: OMAHA STATE: NE ZIP: 68164 D 1 primary_doc.xml X0707 D LIVE 0001043961 TRANSGENOMIC INC 12325 EMMET ST OMAHA NE NEBRASKA 68164 4024525400 DELAWARE None None Corporation true Paul Kinnon 12325 Emmet Street Omaha NE NEBRASKA 68164 Executive Officer Director Robert M Patzig 12325 Emmet Street Omaha NE NEBRASKA 68164 Director Doit L Koppler 12325 Emmet Street Omaha NE NEBRASKA 68164 Director Michael Luther 12325 Emmet Street Omaha NE NEBRASKA 68164 Director Mya Thomae 12325 Emmet Street Omaha NE NEBRASKA 68164 Director Biotechnology $1,000,001 - $5,000,000 06b false 2017-04-13 false true true false 0 Aegis Capital Corp. 15007 None None 810 7th Avenue 18th & 22nd Floor New York NY NEW YORK 10019 CA CALIFORNIA CT CONNECTICUT NY NEW YORK false 1250000 1150000 100000 false 5 84000 true 0 Aegis Capital Corp. received warrants to acquire 168,000 shares of Transgenomic, Inc. common stock 0 false TRANSGENOMIC INC Paul Kinnon Paul Kinnon President and Chief Executive Officer 2017-04-26